SEC Form 4 · accession 0001209191-17-009970
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry E Greene
Director
Period of report
Feb 9, 2017
Accepted (ET)
Feb 13, 2017 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 9, 2017 | M | 723 | $22.13 | A | 723 | D | |
| Common StockF1 | Feb 9, 2017 | S | 723 | $22.65 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock OptionF1,F2 | $22.13 | Feb 9, 2017 | M | 723 | D | — | Feb 14, 2017 | Common Stock | 723 | 0 | D |
Explanation of responses
- F1Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2017 on the expiration date reported within Table II unless exercised.
- F2The shares subject to these options vested in installments and were fully vested on 2/14/2008.